The concept with which the Graz-based company Tyromotion made it from university to world market leader is taken up in “die wirtschaft”. The SHS portfolio company from the SHS IV fund develops robotic and computer-supported therapy devices that support patients in rehabilitation after a stroke, multiple sclerosis or spinal cord injury. Tyromotion uses a playful […]
Digitization in the healthcare industry is progressing only very slowly due to the high density of regulation and complex development procedures. SHS will now invest its fifth fund (planned volume: EUR 150 million) in digital health companies for the first time. SHS Managing Partner Hubertus Leonhardt outlines the particular difficulties involved in investing in medical […]
The financing of new products in the health care industry is often difficult in Germany, as there is a lack of capital. The SHS Beteiligungsgesellschaft is now providing new capital, at least for some of the inventors: In the so-called First Closing, SHS has received commitments for more than 90 million euros from investors in […]
In mid-June the SHS portfolio company Novo announced the acquisition of Innocath. The Duisburg-based company specializes in the care of ventilated patients. Novo Klinik-Service, based in Bergheim, North Rhine-Westphalia, distributes medical equipment and medical technology solutions for intensive care, anaesthesia and nursing.
The start-up company CoreMedic has for the first time used its minimally invasive repair kits for the treatment of herniated valve diseases in a human operation. The operation was successful. SHS only acquired a stake in the company in 2017 with the aim of further developing the product.
The SHS portfolio company phenox, a strongly growing company in the field of neurointerventional stroke treatment, was portrayed by the WAZ. The company receives a grant of EUR 2.1 million from the Federal Ministry of Education and Research (BMBF) for its “anti-thrombosis” technology. This supports the development of coated implants for the treatment of brain […]
The article portrays the SHS portfolio company numares and provides insights into the company’s development and product portfolio. numares develops and sells diagnostic test systems and focuses on nuclear magnetic resonance (NMR) spectroscopy, machine learning and artificial intelligence.
© All rights reserved. Frankfurter Allgemeine Zeitung GmbH, Frankfurt. Provided by the Frankfurter Allgemeine Archiv SHS partner Dr. André Zimmermann reports in an interview with the FAZ on the new medical technology fund of SHS, which like its successful predecessor fund aims to invest in innovative life science companies in German-speaking countries and now also […]
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information